---
figid: PMC4319431__JCI80420.f1
figlink: /pmc/articles/PMC4319431/figure/F1/
number: Figure 1
caption: There are several potential strategies to improve the clinical efficacy of
  these PARAs. One strategy would be to augment potency by increasing the oligomeric
  state of Apo2L/TRAIL or the affinity of agonistic anti-DR4 or anti-DR5 antibodies
  for Fcγ receptors (blue asterisks). Another strategy to improve efficacy would be
  the implementation of predictive and pharmacodynamic diagnostic biomarkers that
  might help predict or determine whether a patient’s cancer is sensitive (green asterisks)
  or resistant (red asterisks) to PARA treatment. A third approach would be to improve
  synthetic lethality against cancer cells by combining PARAs with pharmacological
  agents that target various other intracellular signaling components or modulators
  of the apoptotic pathways (black asterisks). BAX/BAK, BCL-2–associated X protein/BCL-2
  antagonist killer 1; BCL-2/XL, B cell lymphoma-2/extra long; BID, BH3-interacting
  domain death agonist; cFLIP, cellular FLICE-inhibitory protein; CUL3, cullin 3;
  DISC, death-inducing signaling complex; FADD, Fas-associated death domain; FUT3/6,
  fucosyltransferase 3/6; GALNT14/3, polypeptide N-acetylgalactosaminyltransferase
  14/3; SMAC, second mitochondria–derived activator of caspases; TRAF2, TNF receptor–associated
  factor 2; XIAP, X-linked inhibitor of apoptosis.
pmcid: PMC4319431
papertitle: 'Targeting the extrinsic apoptotic pathway in cancer: lessons learned
  and future directions.'
reftext: Avi Ashkenazi. J Clin Invest. 2015 Feb 2;125(2):487-489.
pmc_ranked_result_index: '80606'
pathway_score: 0.9671196
filename: JCI80420.f1.jpg
figtitle: 'Targeting the extrinsic apoptotic pathway in cancer: lessons learned and
  future directions'
year: '2015'
organisms: Homo sapiens
ndex: f88bb3ff-dec5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4319431__JCI80420.f1.html
  '@type': Dataset
  description: There are several potential strategies to improve the clinical efficacy
    of these PARAs. One strategy would be to augment potency by increasing the oligomeric
    state of Apo2L/TRAIL or the affinity of agonistic anti-DR4 or anti-DR5 antibodies
    for Fcγ receptors (blue asterisks). Another strategy to improve efficacy would
    be the implementation of predictive and pharmacodynamic diagnostic biomarkers
    that might help predict or determine whether a patient’s cancer is sensitive (green
    asterisks) or resistant (red asterisks) to PARA treatment. A third approach would
    be to improve synthetic lethality against cancer cells by combining PARAs with
    pharmacological agents that target various other intracellular signaling components
    or modulators of the apoptotic pathways (black asterisks). BAX/BAK, BCL-2–associated
    X protein/BCL-2 antagonist killer 1; BCL-2/XL, B cell lymphoma-2/extra long; BID,
    BH3-interacting domain death agonist; cFLIP, cellular FLICE-inhibitory protein;
    CUL3, cullin 3; DISC, death-inducing signaling complex; FADD, Fas-associated death
    domain; FUT3/6, fucosyltransferase 3/6; GALNT14/3, polypeptide N-acetylgalactosaminyltransferase
    14/3; SMAC, second mitochondria–derived activator of caspases; TRAF2, TNF receptor–associated
    factor 2; XIAP, X-linked inhibitor of apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP3
  - BAK1
  - TNFSF10
  - TRAF2
  - PIK3CB
  - BID
  - MAP2K2
  - GALNT14
  - PIK3R3
  - AKT1
  - AKT2
  - PIK3CG
  - MAP2K1
  - XIAP
  - PIK3CA
  - ARAF
  - TNFRSF10B
  - CDH1
  - FADD
  - KRAS
  - RAF1
  - AKT3
  - HRAS
  - DIABLO
  - MAPK3
  - NRAS
  - MAPK1
  - BCL2L1
  - FUT3
  - TNFRSF10A
  - PIK3CD
  - CFLAR
  - BCL2
  - GALNT3
  - BAX
  - PIK3R6
  - CUL3
  - PIK3R4
  - CASP7
  - BRAF
  - PIK3R5
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: '"Caspase-3,7"""'
  symbol: Caspase_3_7
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: BAX/BAK
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: '"Apo2L/TRAIL"""'
  symbol: TRAIL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: TRAF2*
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: BID
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: RAS/RAF/MEK/ERK*
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: GALNT14/3
  symbol: GALNT14
  source: hgnc_symbol
  hgnc_symbol: GALNT14
  entrez: '79623'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: '"Apo2L/TRAIL"""'
  symbol: Apo-2L
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: PI3K/AKT*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKT*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAS/RAF/MEK/ERK*
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: XIAP*
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS/RAF/MEK/ERK*
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: DR4/DR5*
  symbol: DR5
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10B
  entrez: '8795'
- word: E-cadherin'
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: -FADD*
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: RAS/RAF/MEK/ERK*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS/RAF/MEK/ERK*
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K/AKT*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAS/RAF/MEK/ERK*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: SMAC
  symbol: SMAC
  source: hgnc_alias_symbol
  hgnc_symbol: DIABLO
  entrez: '56616'
- word: RAS/RAF/MEK/ERK*
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS/RAF/MEK/ERK*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS/RAF/MEK/ERK*
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: BCL-2/X,
  symbol: Bcl-X
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: '"FUT3/6"""'
  symbol: FUT3
  source: hgnc_symbol
  hgnc_symbol: FUT3
  entrez: '2525'
- word: DR4/DR5*
  symbol: DR4
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10A
  entrez: '8797'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: -CFLIP*
  symbol: c-FLIP
  source: hgnc_alias_symbol
  hgnc_symbol: CFLAR
  entrez: '8837'
- word: BCL-2/X,
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: GALNT14/3
  symbol: GALNT3
  source: hgnc_symbol
  hgnc_symbol: GALNT3
  entrez: '2591'
- word: BAX/BAK
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: -CUL3*
  symbol: CUL3
  source: hgnc_symbol
  hgnc_symbol: CUL3
  entrez: '8452'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: '"Caspase-3,7"""'
  symbol: Caspase_3_7
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: RAS/RAF/MEK/ERK*
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K/AKT*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
